VIA
ELV icon

Virtus Investment Advisers’s Elevance Health ELV Stock Holding History

Virtus Investment Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55
Closed -$28.2K – 297
2022
Q4 		$28.2K Hold
55
– – 0.02% 316
2022
Q3 		$25K Buy
+55
New +$26.3K 0.01% 366
2018
Q1 		– Sell
-6,398
Closed -$1.44M – 139
2017
Q4 		$1.44M Sell
6,398
-1,067
-14% -$227K 0.16% 174
2017
Q3 		$1.42M Sell
7,465
-1,102
-13% -$210K 0.15% 181
2017
Q2 		$1.61M Sell
8,567
-1,989
-19% -$357K 0.16% 176
2017
Q1 		$1.75M Sell
10,556
-1,351
-11% -$215K 0.15% 180
2016
Q4 		$1.71M Sell
11,907
-8,793
-42% -$1.18M 0.13% 198
2016
Q3 		$2.59M Buy
+20,700
New +$2.67M 0.17% 187

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Virtus Investment Advisers's ELV Position: Q1 2023 in Review

Virtus Investment Advisers sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 55 shares — an estimated $28.2K sold.

Virtus Investment Advisers first reported a position in ELV in Q3 2016 and held it in 8 quarters. The position peaked at $2.59M in Q3 2016. 1,517 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Virtus Investment Advisers reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Virtus Investment Advisers sold 55 Elevance Health shares in Q1 2023, an estimated $28.2K.
  • Virtus Investment Advisers first reported a position in Elevance Health in Q3 2016 and held it in 8 quarters.
  • Virtus Investment Advisers's Elevance Health position peaked at $2.59M in Q3 2016.
  • 1,517 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Virtus Investment Advisers's 13F filing for Q1 2023, filed 15 May 2023.